Biomotion Sciences Warrant
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for … Read more
Biomotion Sciences Warrant (SLXNW) - Net Assets
Latest net assets as of September 2025: $6.98 Million USD
Based on the latest financial reports, Biomotion Sciences Warrant (SLXNW) has net assets worth $6.98 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.61 Million) and total liabilities ($4.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.98 Million |
| % of Total Assets | 60.07% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Biomotion Sciences Warrant - Net Assets Trend (2020–2024)
This chart illustrates how Biomotion Sciences Warrant's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Biomotion Sciences Warrant (2020–2024)
The table below shows the annual net assets of Biomotion Sciences Warrant from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-3.99 Million | +66.91% |
| 2023-12-31 | $-12.06 Million | -70.31% |
| 2022-12-31 | $-7.08 Million | -106.16% |
| 2021-12-31 | $114.91 Million | +67694.90% |
| 2020-12-31 | $-169.99K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Biomotion Sciences Warrant's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4305814000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.00K | % |
| Other Components | $39.26 Million | % |
| Total Equity | $-3.99 Million | 100.00% |
Biomotion Sciences Warrant Competitors by Market Cap
The table below lists competitors of Biomotion Sciences Warrant ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Temir Corp
PINK:TMRR
|
$50.96K |
|
Picton Property Income Ltd
LSE:PCTN
|
$51.02K |
|
VCI Global Limited Ordinary Share
NASDAQ:VCIG
|
$51.03K |
|
RAKUTEN
BE:RAK
|
$51.04K |
|
Truen Co. Ltd.
KO:417790
|
$50.91K |
|
Solidwizard Technology Co., Ltd.
TWO:8416
|
$50.91K |
|
STANDARD SUPPLY NK -10
F:D6Z
|
$50.87K |
|
Filtronic
LSE:FTC
|
$50.85K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Biomotion Sciences Warrant's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -15,476,000 to -3,989,000, a change of 11,487,000.
- Net loss of 16,443,000 reduced equity.
- New share issuances of 3,054,000 increased equity.
- Other factors increased equity by 24,876,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-16.44 Million | -412.21% |
| Share Issuances | $3.05 Million | +76.56% |
| Other Changes | $24.88 Million | +623.61% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Biomotion Sciences Warrant's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $-0.10 | $0.02 | x |
| 2021-12-31 | $69.60 | $0.02 | x |
| 2022-12-31 | $-6.37 | $0.02 | x |
| 2023-12-31 | $-22.72 | $0.02 | x |
| 2024-12-31 | $-6.39 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Biomotion Sciences Warrant utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-0.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-178.86K |
| 2021 | -0.66% | 0.00% | 0.00x | 1.00x | $-12.25 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $1.65 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.39 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-16.04 Million |
Industry Comparison
This section compares Biomotion Sciences Warrant's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Biomotion Sciences Warrant (SLXNW) | $6.98 Million | 0.00% | 0.66x | $50.92K |
| Abcam plc (ABCZF) | $148.21 Million | 17.14% | 0.19x | $5.00 Billion |
| Able View Global Inc. Warrant (ABLVW) | $7.74 Million | 76.78% | 1.27x | $327.05K |
| Above Food Ingredients Inc. Warrants (ABVEW) | $-46.26 Million | 0.00% | 0.00x | $5.68 Million |
| Adamas Trust, Inc. (ADAMG) | $2.31 Billion | -12.50% | 1.02x | $2.10 Billion |
| ADS-TEC ENERGY PLC Warrant (ADSEW) | $13.74 Million | 0.00% | 2.67x | $10.13 Million |
| Alliance Entertainment Holding Corporation Warrants (AENTW) | $108.93 Million | 26.27% | 3.34x | $2.11 Million |
| Forafric Global PLC Warrants (AFRIW) | $29.21 Million | -43.40% | 9.60x | $2.20 Million |
| Centurion Acquisition Corp. Warrant (ALFUW) | $282.84 Million | 1.97% | 0.05x | $4.81 Million |
| Alliance Trust PLC (ALITF) | $3.02 Billion | 7.45% | 0.13x | $117.77K |
| Alvotech Warrant (ALVOW) | $-412.77 Million | 0.00% | 0.00x | $31.83 Million |